Global Antibody-drug Conjugates Market Growth 2020-2025

Publisher Name :
Date: 01-Oct-2020
No. of pages: 134

According to this study, over the next five years the Antibody-drug Conjugates market will register a 3.1%% CAGR in terms of revenue, the global market size will reach $ 2926.2 million by 2025, from $ 2588.6 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Antibody-drug Conjugates business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Antibody-drug Conjugates market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Antibody-drug Conjugates, covering the supply chain analysis, impact assessment to the Antibody-drug Conjugates market size growth rate in several scenarios, and the measures to be undertaken by Antibody-drug Conjugates companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Adcetris

- Kadcyla

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Breast Cancer

- Lymphoma

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- ImmunoGen

- Seattle Genetics

- Takeda

- Roche

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Antibody-drug Conjugates consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Antibody-drug Conjugates market by identifying its various subsegments.

- Focuses on the key global Antibody-drug Conjugates manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Antibody-drug Conjugates with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Antibody-drug Conjugates submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Antibody-drug Conjugates Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antibody-drug Conjugates Consumption 2015-2025
2.1.2 Antibody-drug Conjugates Consumption CAGR by Region
2.2 Antibody-drug Conjugates Segment by Type
2.2.1 Adcetris
2.2.2 Kadcyla
2.3 Antibody-drug Conjugates Consumption by Type
2.3.1 Global Antibody-drug Conjugates Consumption Market Share by Type (2015-2020)
2.3.2 Global Antibody-drug Conjugates Revenue and Market Share by Type (2015-2020)
2.3.3 Global Antibody-drug Conjugates Sale Price by Type (2015-2020)
2.4 Antibody-drug Conjugates Segment by Application
2.4.1 Breast Cancer
2.4.2 Lymphoma
2.5 Antibody-drug Conjugates Consumption by Application
2.5.1 Global Antibody-drug Conjugates Consumption Market Share by Type (2015-2020)
2.5.2 Global Antibody-drug Conjugates Value and Market Share by Type (2015-2020)
2.5.3 Global Antibody-drug Conjugates Sale Price by Type (2015-2020)

3 Global Antibody-drug Conjugates by Company
3.1 Global Antibody-drug Conjugates Sales Market Share by Company
3.1.1 Global Antibody-drug Conjugates Sales by Company (2018-2020)
3.1.2 Global Antibody-drug Conjugates Sales Market Share by Company (2018-2020)
3.2 Global Antibody-drug Conjugates Revenue Market Share by Company
3.2.1 Global Antibody-drug Conjugates Revenue by Company (2018-2020)
3.2.2 Global Antibody-drug Conjugates Revenue Market Share by Company (2018-2020)
3.3 Global Antibody-drug Conjugates Sale Price by Company
3.4 Global Antibody-drug Conjugates Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Antibody-drug Conjugates Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Antibody-drug Conjugates Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Antibody-drug Conjugates by Regions
4.1 Antibody-drug Conjugates by Regions
4.2 Americas Antibody-drug Conjugates Consumption Growth
4.3 APAC Antibody-drug Conjugates Consumption Growth
4.4 Europe Antibody-drug Conjugates Consumption Growth
4.5 Middle East & Africa Antibody-drug Conjugates Consumption Growth

5 Americas
5.1 Americas Antibody-drug Conjugates Consumption by Countries
5.1.1 Americas Antibody-drug Conjugates Consumption by Countries (2015-2020)
5.1.2 Americas Antibody-drug Conjugates Value by Countries (2015-2020)
5.2 Americas Antibody-drug Conjugates Consumption by Type
5.3 Americas Antibody-drug Conjugates Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Antibody-drug Conjugates Consumption by Regions
6.1.1 APAC Antibody-drug Conjugates Consumption by Regions (2015-2020)
6.1.2 APAC Antibody-drug Conjugates Value by Regions (2015-2020)
6.2 APAC Antibody-drug Conjugates Consumption by Type
6.3 APAC Antibody-drug Conjugates Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Antibody-drug Conjugates by Countries
7.1.1 Europe Antibody-drug Conjugates Consumption by Countries (2015-2020)
7.1.2 Europe Antibody-drug Conjugates Value by Countries (2015-2020)
7.2 Europe Antibody-drug Conjugates Consumption by Type
7.3 Europe Antibody-drug Conjugates Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Antibody-drug Conjugates by Countries
8.1.1 Middle East & Africa Antibody-drug Conjugates Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Antibody-drug Conjugates Value by Countries (2015-2020)
8.2 Middle East & Africa Antibody-drug Conjugates Consumption by Type
8.3 Middle East & Africa Antibody-drug Conjugates Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Antibody-drug Conjugates Distributors
10.3 Antibody-drug Conjugates Customer

11 Global Antibody-drug Conjugates Market Forecast
11.1 Global Antibody-drug Conjugates Consumption Forecast (2021-2025)
11.2 Global Antibody-drug Conjugates Forecast by Regions
11.2.1 Global Antibody-drug Conjugates Forecast by Regions (2021-2025)
11.2.2 Global Antibody-drug Conjugates Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Antibody-drug Conjugates Forecast by Type
11.8 Global Antibody-drug Conjugates Forecast by Application

12 Key Players Analysis
12.1 ImmunoGen
12.1.1 Company Information
12.1.2 Antibody-drug Conjugates Product Offered
12.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 ImmunoGen Latest Developments
12.2 Seattle Genetics
12.2.1 Company Information
12.2.2 Antibody-drug Conjugates Product Offered
12.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Seattle Genetics Latest Developments
12.3 Takeda
12.3.1 Company Information
12.3.2 Antibody-drug Conjugates Product Offered
12.3.3 Takeda Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Takeda Latest Developments
12.4 Roche
12.4.1 Company Information
12.4.2 Antibody-drug Conjugates Product Offered
12.4.3 Roche Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Roche Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Antibody-drug Conjugates Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Adcetris
Table 5. Major Players of Kadcyla
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Antibody-drug Conjugates Consumption Market Share by Type (2015-2020)
Table 8. Global Antibody-drug Conjugates Revenue by Type (2015-2020) ($ million)
Table 9. Global Antibody-drug Conjugates Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Antibody-drug Conjugates Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Antibody-drug Conjugates Consumption Market Share by Application (2015-2020)
Table 13. Global Antibody-drug Conjugates Value by Application (2015-2020)
Table 14. Global Antibody-drug Conjugates Value Market Share by Application (2015-2020)
Table 15. Global Antibody-drug Conjugates Sale Price by Application (2015-2020)
Table 16. Global Antibody-drug Conjugates Sales by Company (2017-2019) (Kg)
Table 17. Global Antibody-drug Conjugates Sales Market Share by Company (2017-2019)
Table 18. Global Antibody-drug Conjugates Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Antibody-drug Conjugates Revenue Market Share by Company (2017-2019)
Table 20. Global Antibody-drug Conjugates Sale Price by Company (2017-2019)
Table 21. Global Antibody-drug Conjugates Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Antibody-drug Conjugates Products Offered
Table 23. Antibody-drug Conjugates Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Antibody-drug Conjugates Consumption by Regions 2015-2020 (Kg)
Table 25. Global Antibody-drug Conjugates Consumption Market Share by Regions 2015-2020
Table 26. Global Antibody-drug Conjugates Value by Regions 2015-2020 ($ Millions)
Table 27. Global Antibody-drug Conjugates Value Market Share by Regions 2015-2020
Table 28. Americas Antibody-drug Conjugates Consumption by Countries (2015-2020) (Kg)
Table 29. Americas Antibody-drug Conjugates Consumption Market Share by Countries (2015-2020)
Table 30. Americas Antibody-drug Conjugates Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Antibody-drug Conjugates Value Market Share by Countries (2015-2020)
Table 32. Americas Antibody-drug Conjugates Consumption by Type (2015-2020) (Kg)
Table 33. Americas Antibody-drug Conjugates Consumption Market Share by Type (2015-2020)
Table 34. Americas Antibody-drug Conjugates Consumption by Application (2015-2020) (Kg)
Table 35. Americas Antibody-drug Conjugates Consumption Market Share by Application (2015-2020)
Table 36. APAC Antibody-drug Conjugates Consumption by Countries (2015-2020) (Kg)
Table 37. APAC Antibody-drug Conjugates Consumption Market Share by Countries (2015-2020)
Table 38. APAC Antibody-drug Conjugates Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Antibody-drug Conjugates Value Market Share by Regions (2015-2020)
Table 40. APAC Antibody-drug Conjugates Consumption by Type (2015-2020) (Kg)
Table 41. APAC Antibody-drug Conjugates Consumption Market Share by Type (2015-2020)
Table 42. APAC Antibody-drug Conjugates Consumption by Application (2015-2020) (Kg)
Table 43. APAC Antibody-drug Conjugates Consumption Market Share by Application (2015-2020)
Table 44. Europe Antibody-drug Conjugates Consumption by Countries (2015-2020) (Kg)
Table 45. Europe Antibody-drug Conjugates Consumption Market Share by Countries (2015-2020)
Table 46. Europe Antibody-drug Conjugates Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Antibody-drug Conjugates Value Market Share by Countries (2015-2020)
Table 48. Europe Antibody-drug Conjugates Consumption by Type (2015-2020) (Kg)
Table 49. Europe Antibody-drug Conjugates Consumption Market Share by Type (2015-2020)
Table 50. Europe Antibody-drug Conjugates Consumption by Application (2015-2020) (Kg)
Table 51. Europe Antibody-drug Conjugates Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Antibody-drug Conjugates Consumption by Countries (2015-2020) (Kg)
Table 53. Middle East & Africa Antibody-drug Conjugates Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Antibody-drug Conjugates Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Antibody-drug Conjugates Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Antibody-drug Conjugates Consumption by Type (2015-2020) (Kg)
Table 57. Middle East & Africa Antibody-drug Conjugates Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Antibody-drug Conjugates Consumption by Application (2015-2020) (Kg)
Table 59. Middle East & Africa Antibody-drug Conjugates Consumption Market Share by Application (2015-2020)
Table 60. Antibody-drug Conjugates Distributors List
Table 61. Antibody-drug Conjugates Customer List
Table 62. Global Antibody-drug Conjugates Consumption Forecast by Countries (2021-2025) (Kg)
Table 63. Global Antibody-drug Conjugates Consumption Market Forecast by Regions
Table 64. Global Antibody-drug Conjugates Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Antibody-drug Conjugates Value Market Share Forecast by Regions
Table 66. Global Antibody-drug Conjugates Consumption Forecast by Type (2021-2025) (Kg)
Table 67. Global Antibody-drug Conjugates Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Antibody-drug Conjugates Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Antibody-drug Conjugates Value Market Share Forecast by Type (2021-2025)
Table 70. Global Antibody-drug Conjugates Consumption Forecast by Application (2021-2025) (Kg)
Table 71. Global Antibody-drug Conjugates Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Antibody-drug Conjugates Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Antibody-drug Conjugates Value Market Share Forecast by Application (2021-2025)
Table 74. ImmunoGen Product Offered
Table 75. ImmunoGen Antibody-drug Conjugates Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 76. ImmunoGen Main Business
Table 77. ImmunoGen Latest Developments
Table 78. ImmunoGen Basic Information, Company Total Revenue (in $ million), Antibody-drug Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 79. Seattle Genetics Product Offered
Table 80. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 81. Seattle Genetics Main Business
Table 82. Seattle Genetics Latest Developments
Table 83. Seattle Genetics Basic Information, Company Total Revenue (in $ million), Antibody-drug Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 84. Takeda Product Offered
Table 85. Takeda Antibody-drug Conjugates Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 86. Takeda Main Business
Table 87. Takeda Latest Developments
Table 88. Takeda Basic Information, Company Total Revenue (in $ million), Antibody-drug Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 89. Roche Product Offered
Table 90. Roche Antibody-drug Conjugates Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 91. Roche Main Business
Table 92. Roche Latest Developments
Table 93. Roche Basic Information, Company Total Revenue (in $ million), Antibody-drug Conjugates Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Antibody-drug Conjugates
Figure 2. Antibody-drug Conjugates Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Antibody-drug Conjugates Consumption Growth Rate 2015-2025 (Kg)
Figure 5. Global Antibody-drug Conjugates Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Adcetris
Figure 7. Product Picture of Kadcyla
Figure 8. Global Antibody-drug Conjugates Consumption Market Share by Type (2015-2020)
Figure 9. Global Antibody-drug Conjugates Value Market Share by Type (2015-2020)
Figure 10. Antibody-drug Conjugates Consumed in Breast Cancer
Figure 11. Global Antibody-drug Conjugates Market: Breast Cancer (2015-2020) (Kg)
Figure 12. Global Antibody-drug Conjugates Market: Breast Cancer (2015-2020) ($ Millions)
Figure 13. Antibody-drug Conjugates Consumed in Lymphoma
Figure 14. Global Antibody-drug Conjugates Market: Lymphoma (2015-2020) (Kg)
Figure 15. Global Antibody-drug Conjugates Market: Lymphoma (2015-2020) ($ Millions)
Figure 16. Global Antibody-drug Conjugates Consumption Market Share by Application (2015-2020)
Figure 17. Global Antibody-drug Conjugates Value Market Share by Application (2015-2020)
Figure 18. Global Antibody-drug Conjugates Sales Market Share by Company in 2017
Figure 19. Global Antibody-drug Conjugates Sales Market Share by Company in 2019
Figure 20. Global Antibody-drug Conjugates Revenue Market Share by Company in 2017
Figure 21. Global Antibody-drug Conjugates Revenue Market Share by Company in 2019
Figure 22. Global Antibody-drug Conjugates Sale Price by Company in 2019
Figure 23. Global Antibody-drug Conjugates Consumption Market Share by Regions 2015-2020
Figure 24. Global Antibody-drug Conjugates Value Market Share by Regions 2015-2020
Figure 25. Americas Antibody-drug Conjugates Consumption 2015-2020 (Kg)
Figure 26. Americas Antibody-drug Conjugates Value 2015-2020 ($ Millions)
Figure 27. APAC Antibody-drug Conjugates Consumption 2015-2020 (Kg)
Figure 28. APAC Antibody-drug Conjugates Value 2015-2020 ($ Millions)
Figure 29. Europe Antibody-drug Conjugates Consumption 2015-2020 (Kg)
Figure 30. Europe Antibody-drug Conjugates Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Antibody-drug Conjugates Consumption 2015-2020 (Kg)
Figure 32. Middle East & Africa Antibody-drug Conjugates Value 2015-2020 ($ Millions)
Figure 33. Americas Antibody-drug Conjugates Consumption Market Share by Countries in 2019
Figure 34. Americas Antibody-drug Conjugates Value Market Share by Countries in 2019
Figure 35. Americas Antibody-drug Conjugates Consumption Market Share by Type in 2019
Figure 36. Americas Antibody-drug Conjugates Consumption Market Share by Application in 2019
Figure 37. United States Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 38. United States Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 40. Canada Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 42. Mexico Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Antibody-drug Conjugates Consumption Market Share by Countries in 2019
Figure 44. APAC Antibody-drug Conjugates Value Market Share by Regions in 2019
Figure 45. APAC Antibody-drug Conjugates Consumption Market Share by Type in 2019
Figure 46. APAC Antibody-drug Conjugates Consumption Market Share by Application in 2019
Figure 47. China Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 48. China Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 50. Japan Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 52. Korea Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 54. Southeast Asia Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 55. India Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 56. India Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 58. Australia Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Antibody-drug Conjugates Consumption Market Share by Countries in 2019
Figure 60. Europe Antibody-drug Conjugates Value Market Share by Countries in 2019
Figure 61. Europe Antibody-drug Conjugates Consumption Market Share by Type in 2019
Figure 62. Europe Antibody-drug Conjugates Consumption Market Share by Application in 2019
Figure 63. Germany Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 64. Germany Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 65. France Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 66. France Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 67. UK Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 68. UK Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 70. Italy Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 72. Russia Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Antibody-drug Conjugates Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Antibody-drug Conjugates Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Antibody-drug Conjugates Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa Antibody-drug Conjugates Consumption Market Share by Application in 2019
Figure 77. Egypt Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 78. Egypt Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 80. South Africa Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 82. Israel Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 84. Turkey Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 86. GCC Countries Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 87. Global Antibody-drug Conjugates Consumption Growth Rate Forecast (2021-2025) (Kg)
Figure 88. Global Antibody-drug Conjugates Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 90. Americas Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 91. APAC Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 92. APAC Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 93. Europe Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 94. Europe Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 96. Middle East & Africa Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 97. United States Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 98. United States Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 99. Canada Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 100. Canada Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 101. Mexico Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 102. Mexico Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 103. Brazil Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 104. Brazil Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 105. China Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 106. China Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 107. Japan Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 108. Japan Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 109. Korea Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 110. Korea Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 112. Southeast Asia Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 113. India Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 114. India Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 115. Australia Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 116. Australia Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 117. Germany Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 118. Germany Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 119. France Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 120. France Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 121. UK Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 122. UK Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 123. Italy Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 124. Italy Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 125. Russia Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 126. Russia Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 127. Spain Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 128. Spain Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 129. Egypt Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 130. Egypt Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 131. South Africa Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 132. South Africa Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 133. Israel Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 134. Israel Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 135. Turkey Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 136. Turkey Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 137. GCC Countries Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 138. GCC Countries Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 139. ImmunoGen Antibody-drug Conjugates Market Share (2018-2020)
Figure 140. Seattle Genetics Antibody-drug Conjugates Market Share (2018-2020)
Figure 141. Takeda Antibody-drug Conjugates Market Share (2018-2020)
Figure 142. Roche Antibody-drug Conjugates Market Share (2018-2020)
  • (Post-pandemic Era) - Global Human Fibrinogen Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 26-Oct-2020        Price: US 3650 Onwards        Pages: 130
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • (Post-pandemic Era) - Global Human Fibrinogen Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 26-Oct-2020        Price: US 3620 Onwards        Pages: 136
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Human Fibrinogen Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
    Published: 26-Oct-2020        Price: US 3160 Onwards        Pages: 105
    Summary At the time of this report, the official counts of cases and deaths from COVID-19 have passed 4,000,000 and 280,000. Many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. It should be noted that the impact of the epidemic has accelerated the trend of localization, regionalization and decentralization of the global industrial chain and supply chain, so it is inevitable to reconstruct the global industrial ch......
  • (Post-pandemic Era) - Global Ginkgo Biloba Extract Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 26-Oct-2020        Price: US 3650 Onwards        Pages: 134
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • (Post-pandemic Era) - Global Ginkgo Biloba Extract Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 26-Oct-2020        Price: US 3620 Onwards        Pages: 132
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Ginkgo Biloba Extract Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
    Published: 26-Oct-2020        Price: US 3160 Onwards        Pages: 108
    Summary At the time of this report, the official counts of cases and deaths from COVID-19 have passed 4,000,000 and 280,000. Many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. It should be noted that the impact of the epidemic has accelerated the trend of localization, regionalization and decentralization of the global industrial chain and supply chain, so it is inevitable to reconstruct the global industrial ch......
  • (Post-pandemic Era) - Global Dental Silica Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 26-Oct-2020        Price: US 3650 Onwards        Pages: 133
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • (Post-pandemic Era) - Global Dental Silica Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 26-Oct-2020        Price: US 3620 Onwards        Pages: 135
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Dental Silica Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
    Published: 26-Oct-2020        Price: US 3160 Onwards        Pages: 106
    Summary At the time of this report, the official counts of cases and deaths from COVID-19 have passed 4,000,000 and 280,000. Many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. It should be noted that the impact of the epidemic has accelerated the trend of localization, regionalization and decentralization of the global industrial chain and supply chain, so it is inevitable to reconstruct the global industrial ch......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs